Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

Milan Sonneveld; Willem Pieter Brouwer; HLY (Henry Lik-Yuan) Chan; T Piratvisuth; JD Jia; S Zeuzem; YF Liaw; BE Hansen; H Choi; C Wat; V Pavlovic; A Gaggar; Q Xie; M Buti; Rob de Knegt; HLA Janssen

doi:10.1016/S2468-1253(19)30087-1

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

Milan Sonneveld
, Willem Pieter Brouwer
, HLY (Henry Lik-Yuan) Chan
, T Piratvisuth
, JD Jia
, S Zeuzem
, YF Liaw
, BE Hansen
, H Choi
, C Wat
, V Pavlovic
, A Gaggar
, Q Xie
, M Buti
, Rob de Knegt
, HLA Janssen

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

68 Citations (Scopus)

Original language	English
Pages (from-to)	538-544
Number of pages	7
Journal	Lancet Gastroenterology & Hepatology
Volume	4
Issue number	7
DOIs	https://doi.org/10.1016/S2468-1253(19)30087-1
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-04-20-02-A

Access to Document

10.1016/S2468-1253(19)30087-1

Cite this

Sonneveld, M., Brouwer, W. P., Chan, HLY., Piratvisuth, T., Jia, JD., Zeuzem, S., Liaw, YF., Hansen, BE., Choi, H., Wat, C., Pavlovic, V., Gaggar, A., Xie, Q., Buti, M., de Knegt, R., & Janssen, HLA. (2019). Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study. Lancet Gastroenterology & Hepatology, 4(7), 538-544. https://doi.org/10.1016/S2468-1253(19)30087-1

@article{8467c971477f4429803e838b9471713d,

title = "Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study",

author = "Milan Sonneveld and Brouwer, \{Willem Pieter\} and Chan, \{HLY (Henry Lik-Yuan)\} and T Piratvisuth and JD Jia and S Zeuzem and YF Liaw and BE Hansen and H Choi and C Wat and V Pavlovic and A Gaggar and Q Xie and M Buti and \{de Knegt\}, Rob and HLA Janssen",

year = "2019",

doi = "10.1016/S2468-1253(19)30087-1",

language = "English",

volume = "4",

pages = "538--544",

journal = "Lancet Gastroenterology \& Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd.",

number = "7",

}

Sonneveld, M , Brouwer, WP, Chan, HLY, Piratvisuth, T, Jia, JD, Zeuzem, S, Liaw, YF, Hansen, BE, Choi, H, Wat, C, Pavlovic, V, Gaggar, A, Xie, Q, Buti, M, de Knegt, R & Janssen, HLA 2019, 'Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study', Lancet Gastroenterology & Hepatology, vol. 4, no. 7, pp. 538-544. https://doi.org/10.1016/S2468-1253(19)30087-1

TY - JOUR

T1 - Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

AU - Sonneveld, Milan

AU - Brouwer, Willem Pieter

AU - Chan, HLY (Henry Lik-Yuan)

AU - Piratvisuth, T

AU - Jia, JD

AU - Zeuzem, S

AU - Liaw, YF

AU - Hansen, BE

AU - Choi, H

AU - Wat, C

AU - Pavlovic, V

AU - Gaggar, A

AU - Xie, Q

AU - Buti, M

AU - de Knegt, Rob

AU - Janssen, HLA

PY - 2019

Y1 - 2019

U2 - 10.1016/S2468-1253(19)30087-1

DO - 10.1016/S2468-1253(19)30087-1

M3 - Article

C2 - 30975477

SN - 2468-1253

VL - 4

SP - 538

EP - 544

JO - Lancet Gastroenterology & Hepatology

JF - Lancet Gastroenterology & Hepatology

IS - 7

ER -